D
Debra Garnett
Researcher at National Institutes of Health
Publications - 8
Citations - 516
Debra Garnett is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Substance abuse & Slow-wave sleep. The author has an hindex of 7, co-authored 8 publications receiving 511 citations.
Papers
More filters
Journal ArticleDOI
The experience of insomnia and daytime and nightime functioning
TL;DR: Ten insomniacs and matched control subjects, in whom major physiologic disorders such as sleep apnea and nocturnal myoclonus were ruled out, underwent studies of sleep, temperature, motor activity, cognitive performance, and perception of depth of sleep.
Journal ArticleDOI
Frequency analysis of the sleep EEG in depression.
Wallace B. Mendelson,David A. Sack,Steven P. James,Joseph V. Martin,Richard L. Wagner,Debra Garnett,John Milton,Thomas A. Wehr +7 more
TL;DR: Eight patients with major depressive disorder and matched controls had sleep studies, on which frequency analysis of the electroencephalogram (EEG) was performed, suggesting that mean REM latencies are not always shorter in major depression.
Relationship to Age of Onset and Cerebrospinal Fluid Neuropeptides
Alec Roy,Judith DeJong,Danuta Lamparski,Bryon Adinoff,Ted George,Veronica Moore,Debra Garnett,Michael Kerich,Markku Linnoila +8 more
TL;DR: Results support the notion that age of onset may delineate subgroups of alcoholics with significant clinical and neurochemical differences.
Journal ArticleDOI
A psychophysiological study of insomnia.
TL;DR: Findings suggest that subjectively poor sleep is not necessarily "light" sleep, and there was little relationship between reported habitual aspects of sleep and baseline polygraphically defined sleep variables.
Journal ArticleDOI
REM sleep suppression induced by selective monoamine oxidase inhibitors.
Robert M. Cohen,David Pickar,Debra Garnett,Steven Lipper,J. Christian Gillin,Dennis L. Murphy +5 more
TL;DR: The results were consistent with the hypothesis that selective inhibition of the MAO type A, as produced by clorgyline, is sufficient to induce marked sleep changes and MAO inhibitor-induced receptor changes are proposed to account for the time course of the REM suppression and the REM rebound observed upon withdrawal.